EW Filing
4Filing Date: Jul 30, 2026

Edwards Lifesciences Corp (EW) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001225208-26-006853open_in_new
Total Value$12.6K
Trades1
Insiders1

Transaction Details

Markowitz Wayne
CVP, JAPAC·Direct
Sell · Dispose
Common Stock
Shares-146.31
Price$86.03
Total Value$12.6K
Shares Owned After21.53K
Transaction DateJul 30, 2026

Post-Transaction Holdings

Markowitz Wayne
SecuritySharesChange
Common Stock21.53K-146.31 (-0.67%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-30 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Markowitz Wayne CIK: 0001991414 Role: Officer (CVP, JAPAC) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-30 | Code: S (Open market sale) Shares: -146.3127 | Price: $86.03 Total Value: $12,587.84 Shares Owned After: 21,533.5581 | Ownership: D (Direct) --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-07-30)

keid AI analysis is for reference only and does not constitute investment advice.